Best Practices for Patients With Pain. Commonly Used Over the Counter (OTC) Pain Relievers 5/15/2015



Similar documents
Lora McGuire MS, RN Educator and Consultant Barriers to effective pain relief

Medications for chronic pain

Review of Pharmacological Pain Management

POST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics

Choosing Pain Medicine for Osteoarthritis. A Guide for Consumers

Over the Counter Drugs (OTCs): Considerations for Physical Therapy Practice in Canada

OPIOIDS. Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School

SAFE PAIN MEDICATION PRESCRIBING GUIDELINES

Opioid Analgesics. Week 19

Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients

Blueprint for Prescriber Continuing Education Program

Populations at risk for opioid overdose

A Guide to pain relief medicines For patients receiving Palliative Care

The TIRF REMS Access program is a Food and Drug Administration (FDA) required risk management program

Considerations when Using Controlled Substances to Treat Chronic Pain

Opioids and the Injured Worker Tools for Successful Outcomes

Got Pain? 11/19/2013. Pain Kill Beyond The Pill. Yet it is often inadequately treated.

patient group direction

Visit to hear more of my story or call 211 for help and treatment options

Drug and Alcohol Abuse Training revised: October 2015

How To Get A Tirf

Prescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth

Daily aspirin therapy: Understand the benefits and risks

understanding GI bleeding

PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain

UNIT VIII NARCOTIC ANALGESIA

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians

PAIN RELIEF GUIDE. Tips and advice from your pharmacist.

Pain Management after Surgery Patient Information Booklet

Painkillers (analgesics)

The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool

Weaning off your pain medicine

Naloxone treatment of opioid overdose

Strong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER

Implementing Prescribing Guidelines in the Emergency Department. April 16, 2013

Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain

Iowa Governor s Office of Drug Control Policy

PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications

CDC s Prevention Efforts to Address Prescription Opioid Epidemic

Elements for a public summary. VI.2.1 Overview of disease epidemiology. VI.2.2 Summary of treatment benefits

Treatment with Rivaroxaban

Questions and answers on breast cancer Guideline 10: The management of persistent pain after breast cancer treatment

NEW PATIENTS' INFORMATION SHEET

Like cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.

Abstral Prescriber and Pharmacist Guide

Nurses Self Paced Learning Module on Pain Management

MEDICATION ABUSE IN OLDER ADULTS

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN

A Review of the Impacts of Opiate Use in Ontario: Summary Report

Ultram (tramadol), Ultram ER (tramadol extended-release tablets); Conzip (tramadol extended-release capsules), Ultracet (tramadol / acetaminophen)

Pain Medication Taper Regimen Time frame to taper off days

Pain Management in Palliative and Hospice Care

The Outpatient Knee Replacement Program at Orlando Orthopaedic Center. Jeffrey P. Rosen, MD

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC

Drug Testing to Support Pain Management

Treatment with Apixaban

Planning: Patient Goals and Expected Outcomes The patient will: Remain free of unusual bleeding Maintain effective tissue perfusion Implementation

Prescription Opioid Addiction and Chronic Pain: Non-Addictive Alternatives To Treatment and Management

Prescription Drugs: Abuse and Addiction

Understanding Your Pain

Opioid Dependence Treatment with Buprenorphine/Naloxone: An Overview for Pharmacists and Physicians

MILD TO MODERATE NOTE Medication is listed in increasing order of strength. Ascriptin (Aspirin) (P1-B1,2) - Pain reliever, anti-inflammatory

PRESCRIPTION PAINKILLER OVERDOSES

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths

Nonsteroidal. Drugs (NSAIDs) Anti-Inflammatory. North American Spine Society Public Education Series

Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine. Managing Acute Pain. A Guide for Patients.

Migraine The Problem: Common Symptoms:

Schedule of Controlled Substances

Essential Shared Care Agreement Drugs for Dementia

Drug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008

A Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death

Ask Your Doctor if There May Be a SMARTER CHOICE

Pain is a common symptom reported

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION

EMERGENCY DEPARTMENT VISITS INVOLVING NARCOTIC PAIN RELIEVERS

Marijuana: The changing public opinion 5/12/2014. Mother s little helper: Prescription drug abuse in the 21 st century

Lumbar or Thoracic Fusion +/- Decompression

Opioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist

Prior Authorization Guideline

A. Ketorolac*** B. Naproxen C. Ibuprofen D. Celecoxib

Medical Malpractice Treatment Alprazolam benzodiazepine - A Case Study

October We hope that our tool will be a useful aid in your efforts to improve pain management in your setting. Sincerely,

Update and Review of Medication Assisted Treatments

How To Get A Prescription In Rhode Island

Upstate University Health System Medication Exam - Version A

Dependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania

Ohio Department of Health APRIL 17, 2014

Jane Maxwell, UT Addiction Research Institute, Prescription Pain Medications and Heroin: A Changing Picture

Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013

A handbook for patients COPING WITH CANCER PAIN

2015 REPORT Steven W. Schierholt, Esq. Executive Director

Buy Ibuprofen Gel 10. ibuprofen 400 mg maximum dose. use of ibuprofen after surgery. how much ibuprofen in advil migraine

Ibuprofen Tablets Bp 400 Mg

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

Opioid overdose can occur when a patient misunderstands the directions

Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy

MUSC Opioid Analgesic Comparison Chart

BENZODIAZEPINE CONSIDERATIONS IN WORKERS COMPENSATION: IMPLICATIONS FOR WORK DISABILITY AND CLAIM COSTS By: Michael Erdil MD, FACOEM

Sporadic attacks of severe tension-type headaches may respond to analgesics.

Transcription:

Faculty Best Practices for Patients With Pain Nancy Bishop, RPh Assistant State Pharmacy Director Alabama Department of Public Health Satellite Conference and Live Webcast Wednesday, May 20, 2015 2:00 4:00 p.m. Central Time Produced by the Alabama Department of Public Health Video Communications and Distance Learning Division Commonly Used Over the Counter (OTC) Pain Relievers Acetaminophen Aspirin Ibuprofen Naproxen Combination products: Excedrin Goody Powders Most Commonly Used Prescription (RX) Pain Relievers Hydrocodone and Hydrocodone combination products Oxycodone and Oxycodone combination products Tramadol Pregabalin Gabapentin Acetaminophen Maximum daily dose of 4000 mg per 24 hours (from all sources) Frequent use above maximum daily dose can lead to liver toxicity Added boxed warning in 2011 Limit of 325 mg per dosage unit in prescription medications Acetaminophen Has no peripheral anti - inflammatory activity Has no effect of platelet function Fewer hematologic, GI and renal effects than aspirin Is available in immediate release, biphasic release and extended release 1

Aspirin Has anti - inflammatory, anti - pyretic, and anti - thrombotic properties Use cautiously in children: Reye s syndrome Dose is dependent on indication Higher dose may be needed for thrombosis prophylaxis Aspirin Use with caution when taking a NSAID Overdose can result in renal failure Caution: Bleeding disorders, warfarin, renal disease, peptic ulcers, gastritis, platelet inhibitors High dose and over use can cause tinnitus and hearing loss OTC Combination Products Goody Powders and Excedrin: Contains acetaminophen, aspirin and caffeine Caffeine may increase bioavailability of some analgesics Level 1 interactions: MAOIs and Probenecid OTC Combination Products Dosing limits for adults and elderly: Acetaminophen 4000 mg/day Aspirin 2080 mg/day Caffeine 520 mg/day Risk of serious GI adverse effects including bleeding, ulceration and perforation of stomach and intestines Increased risk of serious cardiovascular thrombotic events, myocardial infarction and stroke Should dose at lowest effective dose for shortest possible duration Not recommended for persistent pain in the elderly 2

Contradicted: After coronary artery bypass graft surgery Patients with NSAID hypersensitivity Patients with salicylate hypersensitivity Patients with sulfonamide hypersensitivity Level 1 (severe) drug - drug interactions: Cidofovir: due to increased risk for nephrotoxicity NSAIDs Black Box Warnings: GI Bleeding GI Perforation Myocardial Infarction Stroke : OTC Ibuprofen 200 mg Advil Motrin Midol Naproxen 220 mg Aleve : RX Celecoxib: Celebrex COX-2 inhibitor Meloxicam: Mobic COX-2 inhibitor but less selective Piroxicam: Feldene Similar in structure to Meloxicam : RX Single daily dose Naproxen dosage units greater than 220 mg Ibuprofen dosage units greater than 200 mg 3

Schedule I: No currently acceptable medical use in the United States Lack accepted safety High potential for abuse Schedule II: High potential for abuse which may lead to severe psychological or physical dependence acceptable medical use in the United States Schedule III: Potential for abuse less than Schedules I or II Schedule IV: Low potential for abuse relative to substance in Schedule III May lead to moderate or low psychological or physical dependence Schedule V: Low potential for abuse relative to substance in Schedule IV Primarily preparations containing limited quantities of certain narcotics Hydrocodone extended release (II) Hydrocodone with acetaminophen (II) Hydrocodone with ibuprofen (II) Oxycodone immediate release (II) Oxycodone extended release (II) Oxycodone with acetaminophen (II) Oxycodone with aspirin (II) Morphine (II) 4

Methadone (II) Fentanyl (II) Meperidine (II) Hydromorphone (II) Codeine (II) Oxymorphone (II) Tramadol (IV) Heroin (I) History of Opium Earliest reference to opium use is in 5000 BC Today heroin is less expensive on the street than prescription p drugs ($15/ bag compared to $10 to $30/ pill of Hydrocodone or Oxycodone) The heroin of today is 50-60% pure compared to 6-10% in the 1970 s Contraindications: GI obstruction Paralytic ileus Respiratory depression Status asthmaticus Black Box Warnings: Respiratory depression Accidental exposure Ethanol ingestion Neonatal opioid withdrawal syndrome Potential for overdose or poisoning Substance abuse No level 1 interactions but medications with CNS activities can be additive Adverse effects: CNS related effects: drowsiness, depression, etc. GI effects: constipation, nausea, etc. Addiction and withdrawal symptoms Respiratory depression which can be fatal Pregabalin (Lyrica): Indicated for diabetic neuropathy, fibromyalgia, neuropathic pain, postherpetic p neuralgia and spinal cord injury Schedule V controlled substance Use with caution in patients taking ACE inhibitors 5

Gabapentin (Neurontin) Indicated for postherpetic neuralgia and restless legs syndrome Ropinirole (Requip): Indicated for restless legs syndrome Oxcarbazepine (Trileptal): Off label use in trigeminal neuralgia Level 1 interactions: Carbamazepine, eslicarbazepine, Ibrutinib, Ranolazine, Selegilline (Transdermal) Carisoprodol (Soma) Indicated for musculoskeletal pain Schedule IV controlled substance Use for no more than 2 to 3 weeks at the lowest effective dose Anti-spasmatic Cyclobenzaprine (Flexeril): Indicated for muscle spasm Off label use in fibromyalgia Baclofen (Lioresal): Indicated for muscle spasms, spasticity and spinal cord injury Anti-migraine Isometheptene / Dichloalphenazone / Acetaminophen (Midrin): Indicated for headache and migraine Give with or without food Anti-migraine Level 1 interactions include disulfiram, MAOIs, and procarbazine Schedule IV Contraindications include cardiac disease, glaucoma, hepatic disease, hypertension, MAOI therapy, and renal disease or failure 6

Beers Criteria Medication List Medications that are potentially inappropriate for older patients Evidence of drug - related problems and adverse drug events All commonly used pain relievers can be found on one of the Beers lists Fall precautions when elderly taking pain medications Red Flag Combinations Trinity Combination of Hydrocodone, Carisoprodol and Alprazolam (or other benzodiazepine) Holy Trinity Combination of Oxycodone, Carisoprodol and Alprazolam (or other benzodiazepine) How to Dispose of Controlled Substances The DEA suggest three options for disposal of controlled Substances: Take - back events Mail - back programs Collection receptacles How to Dispose of Controlled Substances If none of these are available, crush meds and place in cat litter or coffee grounds and discard in trash Patches should be flushed www.deadiversion.usdoj.gov Reference List Clinical Pharmacology- online GeriatricsCareOnline.org CDC/NCHS, National Vital Statistics System Vital Signs: Variation Among States in Prescribing of Opioid Pain Relievers and Benzodiazepines- United States, 2012 (CDC MMWR Weekly Report Vol. 63) CDC, Morbidity and Mortality Weekly Report, 60(43):1489, 2011 Contact Information Nancy Bishop, RPh Assistant State Pharmacy Director Alabama Department of Public Health (334) 206-3014 Nancy.Bishop@adph.state.al.us SAMHSA; Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings 7